🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 48576U106
- Market Cap
- Small Cap
- IPO
- 11/6/2013 · $16.00/share
Business: Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
Company Contact
- CEO
- Richard Paulson
- CFO
- Michael Mason
- Headquarters
- 85 Wells Avenue, 2nd Floor, Newton, MA 02459
- Phone
- 617-658-0600
- Investor Relations
- Elhan Webb · 617-658-0600 · elhan.webb@karyopharm.com